Mixed lymphocyte culture reactivity of fetal baboons: Application for in utero bone marrow transplantation

D. Y. Muirhead, T. J. Kuehl, J. L. Vandeberg, E. M. Menchaca, M. P. Downs, G. David Roodman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Bone marrow transplantation offers a potential cure for patients suffering from genetic diseases such as inborn errors of metabolism. The optimal time to transplant many of these affected individuals would be early in gestation. To date, little information is available on the cellular immune reactivity of fetal primate lymphocytes. Therefore, we tested peripheral blood lymphocytes obtained in utero from baboon fetuses (Papio sp.) for their ability to respond in mixed lymphocyte culture (MLC) against their mothers, against a pool of unrelated animals, and in the case of fetuses given unrelated bone marrow transplants in utero, against their specific bone marrow donors. The majority of fetuses as young as 80 gestational days (182-day normal gestation period) were capable of responding strongly to maternal and unrelated lymphocytes in MLC. Of six fetuses that were transplanted, three did not engraft as indicated by undetectable levels of the donor-specific type B allele of glucose phosphate isomerase in fetal blood samples 1 month post-transplant. The three fetuses that did engraft all lost their grafts before birth. These data demonstrate that fetal lymphocytes obtained in utero can be tested for MLC reactivity and suggest that MLC testing can be used to select appropriate donor-recipient combinations for in utero bone marrow transplantation.

Original languageEnglish
Pages (from-to)263-267
Number of pages5
JournalBone Marrow Transplantation
Volume6
Issue number4
StatePublished - 1990
Externally publishedYes

Fingerprint

Papio
Bone Marrow Transplantation
Lymphocytes
Fetus
Transplants
Tissue Donors
xylose isomerase
Bone Marrow
Mothers
Inborn Errors Metabolism
Pregnancy
Inborn Genetic Diseases
Aptitude
Fetal Blood
Primates
Alleles
Phosphates
Parturition

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Muirhead, D. Y., Kuehl, T. J., Vandeberg, J. L., Menchaca, E. M., Downs, M. P., & Roodman, G. D. (1990). Mixed lymphocyte culture reactivity of fetal baboons: Application for in utero bone marrow transplantation. Bone Marrow Transplantation, 6(4), 263-267.

Mixed lymphocyte culture reactivity of fetal baboons : Application for in utero bone marrow transplantation. / Muirhead, D. Y.; Kuehl, T. J.; Vandeberg, J. L.; Menchaca, E. M.; Downs, M. P.; Roodman, G. David.

In: Bone Marrow Transplantation, Vol. 6, No. 4, 1990, p. 263-267.

Research output: Contribution to journalArticle

Muirhead, DY, Kuehl, TJ, Vandeberg, JL, Menchaca, EM, Downs, MP & Roodman, GD 1990, 'Mixed lymphocyte culture reactivity of fetal baboons: Application for in utero bone marrow transplantation', Bone Marrow Transplantation, vol. 6, no. 4, pp. 263-267.
Muirhead, D. Y. ; Kuehl, T. J. ; Vandeberg, J. L. ; Menchaca, E. M. ; Downs, M. P. ; Roodman, G. David. / Mixed lymphocyte culture reactivity of fetal baboons : Application for in utero bone marrow transplantation. In: Bone Marrow Transplantation. 1990 ; Vol. 6, No. 4. pp. 263-267.
@article{327f96cc84414de18a719f1ffa9d47c8,
title = "Mixed lymphocyte culture reactivity of fetal baboons: Application for in utero bone marrow transplantation",
abstract = "Bone marrow transplantation offers a potential cure for patients suffering from genetic diseases such as inborn errors of metabolism. The optimal time to transplant many of these affected individuals would be early in gestation. To date, little information is available on the cellular immune reactivity of fetal primate lymphocytes. Therefore, we tested peripheral blood lymphocytes obtained in utero from baboon fetuses (Papio sp.) for their ability to respond in mixed lymphocyte culture (MLC) against their mothers, against a pool of unrelated animals, and in the case of fetuses given unrelated bone marrow transplants in utero, against their specific bone marrow donors. The majority of fetuses as young as 80 gestational days (182-day normal gestation period) were capable of responding strongly to maternal and unrelated lymphocytes in MLC. Of six fetuses that were transplanted, three did not engraft as indicated by undetectable levels of the donor-specific type B allele of glucose phosphate isomerase in fetal blood samples 1 month post-transplant. The three fetuses that did engraft all lost their grafts before birth. These data demonstrate that fetal lymphocytes obtained in utero can be tested for MLC reactivity and suggest that MLC testing can be used to select appropriate donor-recipient combinations for in utero bone marrow transplantation.",
author = "Muirhead, {D. Y.} and Kuehl, {T. J.} and Vandeberg, {J. L.} and Menchaca, {E. M.} and Downs, {M. P.} and Roodman, {G. David}",
year = "1990",
language = "English",
volume = "6",
pages = "263--267",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Mixed lymphocyte culture reactivity of fetal baboons

T2 - Application for in utero bone marrow transplantation

AU - Muirhead, D. Y.

AU - Kuehl, T. J.

AU - Vandeberg, J. L.

AU - Menchaca, E. M.

AU - Downs, M. P.

AU - Roodman, G. David

PY - 1990

Y1 - 1990

N2 - Bone marrow transplantation offers a potential cure for patients suffering from genetic diseases such as inborn errors of metabolism. The optimal time to transplant many of these affected individuals would be early in gestation. To date, little information is available on the cellular immune reactivity of fetal primate lymphocytes. Therefore, we tested peripheral blood lymphocytes obtained in utero from baboon fetuses (Papio sp.) for their ability to respond in mixed lymphocyte culture (MLC) against their mothers, against a pool of unrelated animals, and in the case of fetuses given unrelated bone marrow transplants in utero, against their specific bone marrow donors. The majority of fetuses as young as 80 gestational days (182-day normal gestation period) were capable of responding strongly to maternal and unrelated lymphocytes in MLC. Of six fetuses that were transplanted, three did not engraft as indicated by undetectable levels of the donor-specific type B allele of glucose phosphate isomerase in fetal blood samples 1 month post-transplant. The three fetuses that did engraft all lost their grafts before birth. These data demonstrate that fetal lymphocytes obtained in utero can be tested for MLC reactivity and suggest that MLC testing can be used to select appropriate donor-recipient combinations for in utero bone marrow transplantation.

AB - Bone marrow transplantation offers a potential cure for patients suffering from genetic diseases such as inborn errors of metabolism. The optimal time to transplant many of these affected individuals would be early in gestation. To date, little information is available on the cellular immune reactivity of fetal primate lymphocytes. Therefore, we tested peripheral blood lymphocytes obtained in utero from baboon fetuses (Papio sp.) for their ability to respond in mixed lymphocyte culture (MLC) against their mothers, against a pool of unrelated animals, and in the case of fetuses given unrelated bone marrow transplants in utero, against their specific bone marrow donors. The majority of fetuses as young as 80 gestational days (182-day normal gestation period) were capable of responding strongly to maternal and unrelated lymphocytes in MLC. Of six fetuses that were transplanted, three did not engraft as indicated by undetectable levels of the donor-specific type B allele of glucose phosphate isomerase in fetal blood samples 1 month post-transplant. The three fetuses that did engraft all lost their grafts before birth. These data demonstrate that fetal lymphocytes obtained in utero can be tested for MLC reactivity and suggest that MLC testing can be used to select appropriate donor-recipient combinations for in utero bone marrow transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0025151286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025151286&partnerID=8YFLogxK

M3 - Article

C2 - 2150766

AN - SCOPUS:0025151286

VL - 6

SP - 263

EP - 267

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -